[02:15] Bobby Gaspar’s background

[05:10] The science of haematopoietic stem cell therapy

[12:30] Spinning out Orchard Therapeutics

[21:15] Reverse partnerships with pharma

[25:55] Balancing regulatory compliance and innovation

[29:45] Value based payments 

[35:15] Recent approval of Casgevy and gene therapy regulation

[39:45] Failures in a biotech’s journey

[43:00] Impact and meaning in therapeutics companies